Hempvana Cold as Ice Platinum

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults is to apply the product to the affected area no more than 3 to 4 times daily. In the event that the product comes into contact with the hands, it is advised to wash the hands thoroughly with soap and water.

For children under 18 years of age, it is essential to consult a physician prior to use to determine appropriate dosing and administration.

Contraindications

The product should not be used in large quantities, particularly over raw surfaces or blistered areas, as this may exacerbate irritation or lead to adverse effects. Application to wounds or damaged skin is contraindicated due to the potential for increased absorption and systemic effects. Additionally, tight bandaging is not recommended, as it may restrict circulation and contribute to complications.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from excessive heat and open flames to prevent any fire hazards.

When utilizing this product, healthcare professionals should advise patients to avoid contact with the eyes to prevent irritation or injury.

Patients are instructed to discontinue use and consult a healthcare provider if any of the following occur: the condition worsens, symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. These actions are crucial to ensure appropriate medical evaluation and intervention if necessary.

Additionally, this product must be kept out of reach of children. In the event that the product is ingested, it is imperative to seek emergency medical assistance or contact a Poison Control Center immediately to ensure the safety and well-being of the individual.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for external use only and is flammable; therefore, it should be kept away from excessive heat or open flame.

When using this product, patients should avoid contact with the eyes. It is advised not to use the product in large quantities, particularly over raw surfaces or blistered areas, and it should not be applied to wounds or damaged skin. Additionally, patients should refrain from bandaging the area tightly after application.

Patients are instructed to stop use and consult a doctor if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then occur again within a few days.

Furthermore, this product should be kept out of reach of children. In the event that the product is swallowed, it is crucial to seek medical help or contact a Poison Control Center immediately.

Drug Interactions

There are no specific drug interactions reported for this medication. Additionally, no laboratory test interactions have been identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Hempvana Cold as Ice Platinum (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 18 years of age should be evaluated by a physician prior to use. It is essential to consider the specific needs and conditions of this population to ensure appropriate care and treatment.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients may use this medication as no specific safety concerns regarding pregnancy have been noted. There are no dosage modifications required for pregnant individuals, and no special precautions regarding use during pregnancy are included in the prescribing information. Healthcare professionals should continue to monitor the overall health and well-being of pregnant patients while considering the use of this medication.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the product is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific product and the amount ingested; therefore, a thorough assessment by a medical professional is recommended.

Management procedures will typically involve supportive care and symptomatic treatment as necessary. It is important for healthcare providers to monitor the patient closely and provide appropriate interventions based on the clinical presentation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed not to use the product in large quantities, especially over raw surfaces or blistered areas, and to avoid applying it to wounds or damaged skin. It is important to inform patients not to bandage the area tightly after application.

Healthcare providers should counsel patients to stop using the product and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be made aware that if their symptoms clear up and then recur within a few days, they should also seek medical advice.

While using the product, patients should be cautioned to avoid contact with their eyes to prevent irritation or injury.

Storage and Handling

The product is supplied in a tightly closed container to ensure its integrity. It should be stored in a cool, dry place to maintain optimal conditions. Proper storage is essential to preserve the quality and efficacy of the product.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency for adults of no more than 3 to 4 times daily to the affected area. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Hempvana Cold as Ice Platinum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)